This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
As I write, the broad silver ETF, iShares Silver Trust (SLV), is down to $14.87 or 1.65% on the day. I can hear many of my subscribers saying that this wasn't part of the plan. We are at a whisker now from making new lows in Silver. Gold needs to do a bit more but silver is almost there and most assuredly now will print new lows.
Normally whenever investors become risk averse they turn to gold as a protection against an uncertain financial market or global economic outlook. This time around, though, investors are ignoring gold in favor of other safe haven assets. In today’s report, we’ll address the question as to how long this inversion will last and what will finally turn the tide in gold’s favor. Suffice it to say that the gold sellers still enjoy an advantage and don’t look to surrender their control of the market in the immediate term.
EEM IAU SLV
The gold price is still suffering the effects of a strengthening U.S. dollar, as the last few trading sessions have shown. Beyond mere currency considerations, however, something even bigger has held down the gold price on a longer-term basis. In today’s report, we’ll examine the impact that China’s demand is having on gold’s price performance. As we’ll see, China is serving as a major obstacle to a gold turnaround as much as the dollar.
FXI IAU SLV
If it wasn't bad enough that the overpower demand for dollars lately has wreaked havoc on the gold market, gold has also lost two valuable supports. The silver price reversed its recent rally attempt, thereby depriving gold of one such support. The gold and silver mining stocks have also faded in just the last few days, removing yet another potential support. This brings gold back to square one as the bulls have lost all control of the immediate-term trend, as we'll discuss in today's commentary.
The main headline driver for gold's recent weakness remains the ongoing strength in the U.S. dollar. Meanwhile the June rally in the silver price, which would normally have buoyed gold, turned out to be nothing more than a "head fake" as silver has given back its recent gains. Gold now finds itself back in the same position it has been stuck in for most of this spring, namely in a position of weakness.
A stubbornly strong U.S. dollar has kept the technically oversold gold price from launching a rally. While the strong dollar factor is likely to continue weighing against gold in the immediate term, we’ll discuss in this report the growing number of positive factors for gold which suggest the metal’s prospects will improve heading into summer.
Several weeks into a corrective decline for the gold price and investors are asking the question featured in the above headline. Their hopes have been buoyed by the dollar’s latest slip, along with an impressive rally in the silver price. In today’s commentary, we’ll examine the technical evidence which suggests that gold can indeed benefit from these recent developments.
1h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
2018-07-13 - Asif
Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...
2018-07-09 - Asif
Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...
Silicon Investor Message Boards
This table lists all message boards related to SLV / iShares Silver Trust on message board site Silicon Investor.
as of ET